Skip to content

Medicated Paste For Local Application In Ringworm Disease

A Clinical Study To Evaluate The Efficacy Of Edagajadi Lepa In Dadru Kushta

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083250
Enrollment
30
Registered
2025-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Sponsors

Dr Komal Kale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with classical signs and symptoms of Dadru Kushta. 2.Patients of age between 18-60 years, irrespective of gender, society or socio - economic status.

Exclusion criteria

Exclusion criteria: 1.Patients below 18 years of age and above 60 years of age will be excluded. 2.Patients with any systemic disorders that can in some way alter the prognosis & treatment of Dadru Kushta. 3.Patients taken treatment from any other branch of medicine. 4.Patients who complain skin irritation after application of lepa. 5.Pregnant & lactating women.

Design outcomes

Primary

MeasureTime frame
Assessing the following symptoms of dadru kushta such as kandu raga pidaka mandala udgathaTimepoint: 8th day

Secondary

MeasureTime frame
Remission of Symptoms such as mandala raga pidaka udgathaTimepoint: Assessed on 15th day

Countries

India

Contacts

Public ContactDr Avinash K V

K V G Ayurveda Medical College and Hospital

avina138@yahoo.co.in9886937454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026